Meta decides to say no to the Oversight Board’s requests and allow paid publications for ketamine
Meta decided that some of its Oversight Board’s objection messages related to intoxicating drugs weren’t worth the effort, so launch the paid ads for ketamine. Therapeutic ketamine only, of course. Although it is still not approved by the FDA. Meta’s oversight board issued four recommendations in August regarding a 2022 sponsored Instagram post advertising the …